Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-21-000472
Filing Date
2021-05-28
Accepted
2021-05-28 13:38:42
Documents
1
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_7223.html 4  
1 PRIMARY DOCUMENT doc4_7223.xml 4 3092
  Complete submission text file 0001638599-21-000472.txt   4475
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017
Business Address
Rowe Michael M (Reporting) CIK: 0001744774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 21978963